Oracle
today announced the availability of Oracle Health Sciences Clinical Development Center 3.1, a centralized solution for integrating, managing, and analyzing clinical trial information.
The release provides new integration, increased automation, and expanded data standardization to accelerate processing of clinical trial data from multiple sources in a variety of formats and increase user productivity from capture through submission.
Oracle Health Sciences Clinical Development Center 3.1 features automated data load and new execution triggers to increase the timeliness and accuracy of data analysis. The system now automatically reruns routines and programs against the most recent data and notifies users of data and study changes as they occur. The system can also be personalized to notify users of specific events that require their attention.
New governance capabilities allow for the creation of validated libraries to drive standardization, control and reuse of data models, macros, and programs across studies.
Version 3.1 also features a pre-built integration with Oracle Health Sciences InForm GTM electronic data capture (EDC) solution, as well as enhanced support for Medidata Rave clinical data management and EDC platform, automating the set up of Medidata Rave studies and data loading to save time and reduce potential for error. Oracle Health Sciences Clinical Development Center 3.1 now also supports the use of Interactive SAS for program development, and integrates with Oracle’s Siebel Clinical Trial Management System to help auto load study metadata.
The latest version also supports the management of data from studies in multiple languages.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.